phase iii asap trial results: role of remission induction chemotherapy before allohct in r/r aml
Published 1 year ago • 574 plays • Length 6:30Download video MP4
Download video MP3
Similar videos
-
10:34
remission induction therapy prior to allosct in aml: insights from the asap trial
-
3:10
results of phase ii trial of olutasidenib in patients with r/r midh1 aml
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
0:47
overview of the phase iii enhance trial schema
-
1:33
phase i trial results for oral azacitidine and venetoclax in r/r aml
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
9:25
mgus diagnosis: a step-by-step approach
-
1:46
pracinostat for aml update: follow-up analysis and phase iii trial
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
3:52
a phase ii study evaluating the safety and efficacy of olutasidenib in patients with r/r midh1 aml
-
6:31
ash 2022: relapsed/refractory aml - results from the randomized phase iii asap trial
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
2:24
the latest clinical trials into novel aml therapies
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
5:13
phase ii trial of pembrolizumab prior to allo-sct in aml
-
2:49
results from the phase iii echo trial of acalabrutinib plus br in mcl
-
1:30
evaluating the optimal duration of cpx-351 treatment & best timing for allosct consolidation in aml
-
0:39
aml clinical trials: early stage vs. relapse/refractory patients
-
2:34
the evolution of the aml treatment paradigm